Rapid-onset dystonia parkinsonism
Last updated 23 Apr 2024
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
Rapid-onset dystonia parkinsonism (sometimes referred to as RDP) is a rare movement disorder. "Rapid-onset" refers to the abrupt appearance of signs and symptoms over a period of hours to days. Dystonia is a condition characterised by involuntary, sustained muscle contractions. Parkinsonism can include tremors, unusually slow movement (bradykinesia), rigidity, an inability to hold the body upright and balanced (postural instability), and a shuffling walk that can cause falls.
Video picks for Genetic conditionsVideo library
Description
Rapid-onset dystonia parkinsonism (sometimes referred to as RDP) is a rare movement disorder. "Rapid-onset" refers to the abrupt appearance of signs and symptoms over a period of hours to days. Dystonia is a condition characterised by involuntary, sustained muscle contractions. Parkinsonism can include tremors, unusually slow movement (bradykinesia), rigidity, an inability to hold the body upright and balanced (postural instability), and a shuffling walk that can cause falls.
Rapid-onset dystonia parkinsonism causes movement abnormalities that can make it difficult to walk, talk, and carry out other activities of daily life. In people with this disorder, dystonia affects the arms and legs, causing muscle cramping and spasms. Facial muscles are often affected, resulting in problems with speech and swallowing. People with rapid-onset dystonia and parkinsonism may also have headaches; seizures; a distorted view of reality (psychosis); or difficulty processing, learning, and remembering information (cognitive impairment).
The movement abnormalities associated with rapid-onset dystonia parkinsonism tend to begin near the top of the body and move downward. They affect the facial muscles first, then the arms, and finally the legs.
The signs and symptoms of rapid-onset dystonia parkinsonism most commonly appear in adolescence or young adulthood. In some affected individuals, signs and symptoms can be triggered by an infection, physical stress (such as prolonged exercise), emotional stress, or alcohol consumption. The signs and symptoms tend to stabilize within about a month, but they typically do not improve much after that. In some people with this condition, the movement abnormalities abruptly worsen during a second episode several years later.
Some people with rapid-onset dystonia parkinsonism have been diagnosed with anxiety, social phobias, depression, and seizures. It is unclear whether these disorders are related to the genetic changes that cause rapid-onset dystonia parkinsonism.
Inheritance patterns
The source lists the following possible inheritance patterns: Autosomal dominant+Inherited or new variant. More than one pattern can apply in different cases.
Related genes
Other names
Dystonia 12
DYT12
RDP
RODP
Patient picks for Genetic conditions

Brain and nerves
Dystonia
A dystonia is a lasting or frequently recurring and unwanted (involuntary) muscle contraction. It can affect one or more muscles in the body. There is no cure; however, there are different types of treatment which can help. These vary with the type of dystonia that you have.
by Dr Colin Tidy, MRCGP

Brain and nerves
What is vascular parkinsonism and what are the other types of parkinsonism
Parkinsonism is a general term that is used to describe a set of movement problems similar to those seen in Parkinson’s disease. There are a number of possible causes but the most common cause of parkinsonism is Parkinson's disease. Parkinsonism can cause severe problems with basic everyday activities.
by Dr Colin Tidy, MRCGP

Brain and nerves
Young-onset dementia is linked to health and lifestyle, as well as genetics
Many of us fear dementia, not to mention developing it while we're young, but little is known about whether we can prevent it. However, a breakthrough study has identified 15 significant factors linked to young-onset dementia, which develops before the age of 65. And many of these are influenced by your health and lifestyle choices. With around 370,000 people developing young-onset dementia each year worldwide, experts believe this research brings us closer to finding ways to prevent, identify, and treat this devastating disease.
by Amberley Davis

Brain and nerves
Young-onset dementia - what you need to know
Dementia is often seen as something that only affects us during our twilight years. But it can develop much earlier in life. Young-onset dementia refers to dementia diagnosed before the age of 65. We explore the early signs of young-onset dementia, how it’s identified and treated, and practical ways to manage the condition while maintaining quality of life.
by Victoria Raw

Medicine
Tolfenamic acid for migraine
Tolfenamic acid is a non-steroidal anti-inflammatory painkiller. It helps to ease the pain of a migraine headache. Take one tablet as soon as possible at the start of an attack. If needed, you may take a second tablet after an hour or so.
by Michael Stewart, MRPharmS

Neck pain
What causes neck pain?
Dr Sarah Jarvis MBE A sudden-onset (acute) bout of neck pain is common. Two out of three of us will have neck pain at some time in our lives. In most cases it is not due to a serious disease or neck problem and often the exact cause for the pain is not clear. This is called 'nonspecific neck pain'. Most are probably due to minor sprains or bad posture. Full recovery occurs in most cases. The usual advice is to keep the neck active. Painkillers are helpful until the pain eases. Persistent (chronic) pain develops in some cases and further treatment may then be needed. [https://patient.info/health/neck-pain](https://patient.info/health/neck-pain)
by Dr Sarah Jarvis
Related patient information and medicines

Patient information leaflet
Dystonia
A dystonia is a lasting or frequently recurring and unwanted (involuntary) muscle contraction. It can affect one or more muscles in the body. There is no cure; however, there are differen... Secondary dystonia Secondary means the dystonia has been caused by another condition or by something which has happened to you. It is not caused by your.

Patient information leaflet
Antipsychotic medicines
Movement disorders develop in some cases. These include: Parkinsonism - this can cause symptoms similar to those that occur in people with Parkinson's disease Parkinson's disease - for example, tremor and muscle stiffness. Akathisia - this is like a restlessness of the legs. Dystonia Dystonia - this means abnormal movements of the face and body..

Patient information leaflet
Blepharospasm
An increase in blink frequency and strength is called blepharospasm. Blepharospasm is a type of focal dystonia. 'Dystonia' means abnormal, unintentional, sustained muscle contractions or spasms. Parkinson's disease Parkinson's disease /multiple system atrophy/progressive supranuclear palsy. Reaction to medi... Some patients with primary.

Patient information leaflet
Huntington's disease
The symptoms of Huntington's disease can vary from person to person, and gradually worsen over time. Symptoms can develop at any time, but they tend to emerge between the age of 30 ... Movement problems Huntington's disease can cause both involuntary and impaired movement problems, which include: Jerky, involuntary movements in the head, face,.

Patient information leaflet
Torticollis
For example, fixed torticollis that is muscular can arise du... Fixed torticollis can also arise due to incorrect development or fusion of the vertebra (neck bones) in babies. Cervical dystonia Cervical dystonia (also known as spasmodic torticollis) is a problem where abnormal movements develop in the muscles of the neck. It occurs most frequently.

Patient information leaflet
Botox
This leaflet is provided by the British Association of Aesthetic Plastic Surgeons , the professional body responsible for the advancement of education and safety in aesthetic plastic surgery. Botox® and Dysport® are the trade names for Botulinum toxin, produced by a bacterium called Clostridium botulinum. Botox was first used in 1978 to weaken.
Further reading and references
- Rapid-onset dystonia parkinsonism; MedlinePlus, National Library of Medicine.
- Brashear A, Butler IJ, Ozelius LJ, Kramer PI, Farlow MR, Breakefield XO, Dobyns WB. Rapid-onset dystonia-parkinsonism: a report of clinical, biochemical, and genetic studies in two families. Adv Neurol. 1998;78:335-9. No abstract available.
- Brashear A, DeLeon D, Bressman SB, Thyagarajan D, Farlow MR, Dobyns WB. Rapid-onset dystonia-parkinsonism in a second family. Neurology. 1997 Apr;48(4):1066-9. doi: 10.1212/wnl.48.4.1066.
- Brashear A, Dobyns WB, de Carvalho Aguiar P, Borg M, Frijns CJ, Gollamudi S, Green A, Guimaraes J, Haake BC, Klein C, Linazasoro G, Munchau A, Raymond D, Riley D, Saunders-Pullman R, Tijssen MA, Webb D, Zaremba J, Bressman SB, Ozelius LJ. The phenotypic spectrum of rapid-onset dystonia-parkinsonism (RDP) and mutations in the ATP1A3 gene. Brain. 2007 Mar;130(Pt 3):828-35. doi: 10.1093/brain/awl340. Epub 2007 Feb 4.
- Brashear A, Farlow MR, Butler IJ, Kasarskis EJ, Dobyns WB. Variable phenotype of rapid-onset dystonia-parkinsonism. Mov Disord. 1996 Mar;11(2):151-6. doi: 10.1002/mds.870110206.
- Brashear A, Sweadner KJ, Haq I, Napoli E, Ozelius L. ATP1A3-Related Disorder. 2008 Feb 7 [updated 2024 Dec 5]. In: Adam MP, Bick S, Mirzaa GM, Wallace SE, Amemiya A, editors. GeneReviews(R) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. Available from http://www.ncbi.nlm.nih.gov/books/NBK1115/
- de Carvalho Aguiar P, Sweadner KJ, Penniston JT, Zaremba J, Liu L, Caton M, Linazasoro G, Borg M, Tijssen MA, Bressman SB, Dobyns WB, Brashear A, Ozelius LJ. Mutations in the Na+/K+ -ATPase alpha3 gene ATP1A3 are associated with rapid-onset dystonia parkinsonism. Neuron. 2004 Jul 22;43(2):169-75. doi: 10.1016/j.neuron.2004.06.028.
- Dobyns WB, Ozelius LJ, Kramer PL, Brashear A, Farlow MR, Perry TR, Walsh LE, Kasarskis EJ, Butler IJ, Breakefield XO. Rapid-onset dystonia-parkinsonism. Neurology. 1993 Dec;43(12):2596-602. doi: 10.1212/wnl.43.12.2596.
- Haq IU, Snively BM, Sweadner KJ, Suerken CK, Cook JF, Ozelius LJ, Miller C, McCall WV, Whitlow CT, Brashear A. Revising rapid-onset dystonia-parkinsonism: Broadening indications for ATP1A3 testing. Mov Disord. 2019 Oct;34(10):1528-1536. doi: 10.1002/mds.27801. Epub 2019 Jul 30.
- Kabakci K, Isbruch K, Schilling K, Hedrich K, de Carvalho Aguiar P, Ozelius LJ, Kramer PL, Schwarz MH, Klein C. Genetic heterogeneity in rapid onset dystonia-parkinsonism: description of a new family. J Neurol Neurosurg Psychiatry. 2005 Jun;76(6):860-2. doi: 10.1136/jnnp.2004.046730.
- Kramer PL, Mineta M, Klein C, Schilling K, de Leon D, Farlow MR, Breakefield XO, Bressman SB, Dobyns WB, Ozelius LJ, Brashear A. Rapid-onset dystonia-parkinsonism: linkage to chromosome 19q13. Ann Neurol. 1999 Aug;46(2):176-82. doi: 10.1002/1531-8249(199908)46:23.0.co;2-2.
- Pittock SJ, Joyce C, O'Keane V, Hugle B, Hardiman MO, Brett F, Green AJ, Barton DE, King MD, Webb DW. Rapid-onset dystonia-parkinsonism: a clinical and genetic analysis of a new kindred. Neurology. 2000 Oct 10;55(7):991-5. doi: 10.1212/wnl.55.7.991.
- Zaremba J, Mierzewska H, Lysiak Z, Kramer P, Ozelius LJ, Brashear A. Rapid-onset dystonia-parkinsonism: a fourth family consistent with linkage to chromosome 19q13. Mov Disord. 2004 Dec;19(12):1506-10. doi: 10.1002/mds.20258.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

